The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2019 | Improving the management of geriatric myeloma
Ashley Rosko
• 1 Jun 2019
Ashley Elizabeth Rosko, MD, from Ohio State University, Columbus, OH, explains how the management of geriatric myeloma can be improved in the clinical setting at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
